About Deepbridge Life Sciences EIS
The Deepbridge Life Sciences EIS invests in growth-focused life-sciences companies, with Deepbridge taking an active role in guiding and mentoring the management team of the businesses it invests in. The investment strategy is to invest in a diversified portfolio of companies in the biopharmaceuticals, biotechnology and medical-technology sectors. The EIS has a target portfolio size of eight companies and a minimum subscription of £10,000. The target return is £1.70 for every £1 invested.
Deepbridge Life Sciences EIS Summary
| Fund Manager: | Deepbridge Capital |
| Tax Efficiency: | EIS |
| Sector Focus: | Biotech, Medtech, and Pharma |
| Stage Focus: | Early-stage |
| Target Portfolio Size: | 8 companies |
| Minimum Subscription: | £10,000 |
| Closing Date: | Evergreen |
| Website: | Learn more about Deepbridge Life Sciences EIS |
About Deebridge Capital
Launched in 2010, Deepbridge helps build growth businesses, along with a network of investors, technology advisers and industry partners. To date, it has helped to create more than 300 jobs through its investments into companies.
Deepbridge focuses on the technology, life sciences and renewable-energy sectors. It looks for businesses that are innovative and scalable, with the potential to be global; able to demonstrate customer interest and market traction; and which have an energetic and experienced management team.
Contact Deepbridge Capital
- Website: https://www.deepbridgecapital.com
- Address: Deepbridge House, Honeycomb East, Business Park, Chester, CH4 9QN
- Phone: 01244 746000
- Email: [email protected]
Are you the fund manager? Email [email protected] with any comments or amends.